Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
This study is ongoing, but not recruiting participants.
Study NCT00866775   Information provided by Sunovion

First Received on March 18, 2009.   Last Updated on December 4, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Epilepsies, Partial
Epilepsy
Seizures
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Eslicarbazepine acetate
Additional drug interventions recognized in this trial
Anticonvulsants
More general drug interventions related to this trial
Central Nervous System Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sunovion


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services